Salarifar M - Search Results

1

Effect of portable air purifier on indoor air quality: reduced exposure to particulate matter and health risk assessment.

Fazlzadeh M, Hassanvand MS, Nabizadeh R, Shamsipour M, Salarifar M, Naddafi K. Fazlzadeh M, et al. Among authors: salarifar m. Environ Monit Assess. 2022 Aug 4;194(9):638. doi: 10.1007/s10661-022-10255-w. Environ Monit Assess. 2022. PMID: 35925421

2

Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology.

Nadarajah R, Ludman P, Laroche C, Appelman Y, Brugaletta S, Budaj A, Bueno H, Huber K, Kunadian V, Leonardi S, Lettino M, Milasinovic D, Gale CP; NSTEMI investigator group. Nadarajah R, et al. Eur Heart J Qual Care Clin Outcomes. 2023 Sep 12;9(6):552-563. doi: 10.1093/ehjqcco/qcad008. Eur Heart J Qual Care Clin Outcomes. 2023. PMID: 36737420 Free PMC article.

3

Clinical characteristics and risk assessment of ST-segment elevation myocardial infarction patients of an Iranian referral center.

Khalili H, Talasaz AH, Jenab Y, Salarifar M. Khalili H, et al. Among authors: salarifar m. J Cardiovasc Med (Hagerstown). 2012 Nov;13(11):708-15. doi: 10.2459/JCM.0b013e328356a3c6. J Cardiovasc Med (Hagerstown). 2012. PMID: 22914305

4

Percutaneous coronary intervention to treat chronic total occlusion: predictors of technical success and one-year clinical outcome.

Salarifar M, Mousavi MR, Saroukhani S, Nematipour E, Kassaian SE, Alidoosti M, Poorhosseini HR, Haji-Zeinali AM, Nozari Y, Hosseini K, Jalali A. Salarifar M, et al. Tex Heart Inst J. 2014 Feb;41(1):40-7. doi: 10.14503/THIJ-12-2731. Tex Heart Inst J. 2014. PMID: 24512398 Free PMC article.

5

Renal artery stenosis in patients with established coronary artery disease: prevalence and predicting factors.

Khatami MR, Edalati-Fard M, Sadeghian S, Salari-Far M, Bs MP. Khatami MR, et al. Saudi J Kidney Dis Transpl. 2014 Sep;25(5):986-91. doi: 10.4103/1319-2442.139880. Saudi J Kidney Dis Transpl. 2014. PMID: 25193895

6

Twelve-Year History of STEMI Management in Tehran Heart Center: Concomitant Reduction of In-Hospital Mortality and Hospitalization Length.

Saadatagah S, Ghodsi S, Omidi N, Poorhosseini H, Salarifar M, Sadeghian S, Alidoosti M, Kassaian SE, Aghajani H, Mortazavi SH, Hosseini K, Geraiely B. Saadatagah S, et al. Among authors: salarifar m. Arch Iran Med. 2020 Aug 1;23(8):514-521. doi: 10.34172/aim.2020.53. Arch Iran Med. 2020. PMID: 32894962 Free article.

7

Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.

Kassaian SE, Goodarzynejad H, Boroumand MA, Salarifar M, Masoudkabir F, Mohajeri-Tehrani MR, Pourhoseini H, Sadeghian S, Ramezanpour N, Alidoosti M, Hakki E, Saadat S, Nematipour E. Kassaian SE, et al. Among authors: salarifar m. Cardiovasc Diabetol. 2012 Jul 17;11:82. doi: 10.1186/1475-2840-11-82. Cardiovasc Diabetol. 2012. PMID: 22805289 Free PMC article.

8

Effect of minocycline on the left ventricular function following ST-elevation myocardial infarction treated by primary percutaneous coronary intervention.

Nasiri A, Shafiee A, Hosseinsabet A, Talasaz AH, Jalali A, Salarifar M. Nasiri A, et al. Among authors: salarifar m. Trials. 2022 Feb 4;23(1):112. doi: 10.1186/s13063-021-05921-2. Trials. 2022. PMID: 35120566 Free PMC article. Clinical Trial.

9

Outcomes of primary percutaneous coronary intervention in acute myocardial infarction at Tehran Heart Center.

Alidoosti M, Salarifar M, Hajizeinali A, Kassaian SE, Kasemisaleh D, Goodarzynejad H. Alidoosti M, et al. Among authors: salarifar m. Med Princ Pract. 2007;16(5):333-8. doi: 10.1159/000104804. Med Princ Pract. 2007. PMID: 17709919 Free article.

10

Protection from Reperfusion Injury with Intracoronary N-Acetylcysteine in Patients with STEMI Undergoing Primary Percutaneous Coronary Intervention in a Cardiac Tertiary Center.

Nozari Y, Eshraghi A, Talasaz AH, Bahremand M, Salamzadeh J, Salarifar M, Pourhosseini H, Jalali A, Mortazavi SH. Nozari Y, et al. Among authors: salarifar m. Am J Cardiovasc Drugs. 2018 Jun;18(3):213-221. doi: 10.1007/s40256-017-0258-8. Am J Cardiovasc Drugs. 2018. PMID: 29322434 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page